Daniel E. Kolker

Array ( [id] => 4745668 [patent_doc_number] => 20080090270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Nogo receptor homologues and their use' [patent_app_type] => utility [patent_app_number] => 11/906269 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13873 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090270.pdf [firstpage_image] =>[orig_patent_app_number] => 11906269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859629 [patent_doc_number] => 20080268479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'FETUIN-A AS A BIOMARKER FOR MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 11/856454 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6318 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20080268479.pdf [firstpage_image] =>[orig_patent_app_number] => 11856454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502283 [patent_doc_number] => 08034348 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Prevention and treatment of amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 11/842113 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 25 [patent_no_of_words] => 41066 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034348.pdf [firstpage_image] =>[orig_patent_app_number] => 11842113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4565523 [patent_doc_number] => 07846897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Agents for reducing injury to mammalian cells' [patent_app_type] => utility [patent_app_number] => 11/894818 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10589 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846897.pdf [firstpage_image] =>[orig_patent_app_number] => 11894818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599716 [patent_doc_number] => 07977316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Prevention and treatment of amyloidogenic diseases' [patent_app_type] => utility [patent_app_number] => 11/842046 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 41809 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977316.pdf [firstpage_image] =>[orig_patent_app_number] => 11842046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807416 [patent_doc_number] => 20080170994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Macromolecular Compositions that Cross the Blood-Brain Barrier and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/841623 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 47253 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20080170994.pdf [firstpage_image] =>[orig_patent_app_number] => 11841623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4497365 [patent_doc_number] => 07919088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Treatment and delay of onset of synucleinopathic and amyloidogenic disease' [patent_app_type] => utility [patent_app_number] => 11/842054 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 39635 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919088.pdf [firstpage_image] =>[orig_patent_app_number] => 11842054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795375 [patent_doc_number] => 08124081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Prevention and treatment of amyloidogenic diseases' [patent_app_type] => utility [patent_app_number] => 11/842052 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 41906 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124081.pdf [firstpage_image] =>[orig_patent_app_number] => 11842052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688880 [patent_doc_number] => 20080033061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'CATION CONDUCTING GABAA RECEPTORS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 11/838861 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4923 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033061.pdf [firstpage_image] =>[orig_patent_app_number] => 11838861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230786 [patent_doc_number] => 20070292893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Screening for neurotoxic amino acid associated with neurological disorders' [patent_app_type] => utility [patent_app_number] => 11/837899 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14738 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292893.pdf [firstpage_image] =>[orig_patent_app_number] => 11837899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493544 [patent_doc_number] => 07947255 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Fluorescent substrates for neurotransmitter transporters' [patent_app_type] => utility [patent_app_number] => 11/832905 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10687 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947255.pdf [firstpage_image] =>[orig_patent_app_number] => 11832905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5466196 [patent_doc_number] => 20090326396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'DUAL BODY PLETHYSMOGRAPHY APPARATUS AND PROCESS FOR MEASURING BLOOD FLOW BETWEEN THE THORAX AND ABDOMEN (THE TRUNK) AND THE BODY PERIPHERY' [patent_app_type] => utility [patent_app_number] => 12/309757 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3210 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326396.pdf [firstpage_image] =>[orig_patent_app_number] => 12309757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028387 [patent_doc_number] => 20070269834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Methods and compositions for development of drug screening procedures and diagnostic tools' [patent_app_type] => utility [patent_app_number] => 11/827425 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9975 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269834.pdf [firstpage_image] =>[orig_patent_app_number] => 11827425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552759 [patent_doc_number] => 20090286745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'INHIBITION OF ALPHA-SYNUCLEIN AGGREGATION' [patent_app_type] => utility [patent_app_number] => 12/307081 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9266 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286745.pdf [firstpage_image] =>[orig_patent_app_number] => 12307081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473103 [patent_doc_number] => 20090246269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'IDENTIFICATION AND USE OF GPRC VARIANTS IN THE TREATMENT AND DIAGNOSIS OF PARKINSON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/308710 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10204 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246269.pdf [firstpage_image] =>[orig_patent_app_number] => 12308710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391142 [patent_doc_number] => 20090208455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => ' Method for Treating Polyglutamine Expansion Neurodegenerative Diseases' [patent_app_type] => utility [patent_app_number] => 12/305541 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16544 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208455.pdf [firstpage_image] =>[orig_patent_app_number] => 12305541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6571436 [patent_doc_number] => 20100234577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'METHODS FOR PURIFYING ANTIBODIES USING CERAMIC HYDROXYAPATITE' [patent_app_type] => utility [patent_app_number] => 12/304782 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15379 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234577.pdf [firstpage_image] =>[orig_patent_app_number] => 12304782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162085 [patent_doc_number] => 07670783 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Screening for neurotoxic amino acid associated with neurological disorders' [patent_app_type] => utility [patent_app_number] => 11/760668 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14753 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/670/07670783.pdf [firstpage_image] =>[orig_patent_app_number] => 11760668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4909218 [patent_doc_number] => 20080019984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'BLOOD-BRAIN BARRIER TARGETING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/759723 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14631 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019984.pdf [firstpage_image] =>[orig_patent_app_number] => 11759723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880639 [patent_doc_number] => 20080154022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Transport of basic fibroblast growth factor across the blood brain barrier' [patent_app_type] => utility [patent_app_number] => 11/809477 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14206 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20080154022.pdf [firstpage_image] =>[orig_patent_app_number] => 11809477 [rel_patent_id] =>[rel_patent_doc_number] =>)